Search

VE303 (Vedanta Biosciences Inc.) for Prevention of Recurrent Clostridioides Difficile Infection

An investigational oral microbiome restoration therapy proposed to prevent recurrent Clostridioides difficile infection (CDI) in adults following antibacterial treatment for CDI

Complete this form to request the full report